29-02-2024 | Dyslipidemia | Letter to the Editor
Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
Published in: Hepatology International | Issue 2/2024
Login to get access